期刊文献+

血红素氧合酶-1在胃肠道疾病中的作用研究进展 被引量:1

Role of HO-1 in gastrointestinal diseases
下载PDF
导出
摘要 血红素氧合酶-1(hemeoxygenase-1,HO-1)是血红素代谢过程中的限速酶,催化血红素裂解生成等分子的一氧化碳(carbon monoxide,CO)、胆绿素和Fe^(2+)。HO-1是一种公认的保护剂,具有抗炎、抗氧化的作用,并参与调控细胞增殖、凋亡、自噬等重要生命过程,对各种不同组织的创伤均具有保护作用。多项研究显示,HO-1在非甾体抗炎药(non-steroidal anti-inflammatory drugs,NSAIDs)相关性消化道损伤、炎症性肠病(inflammatory bowel disease,IBD)、肠缺血再灌注损伤、消化道肿瘤、胃瘫等多种消化道疾病中均有适应性表达,并起到保护胃肠组织和细胞的重要作用。本文就HO-1在消化道疾病防治中的作用及机制研究进行综述。 Hemeoxygenase-1(HO-1)is a rate-limiting enzyme in heme metabolism,which cleaves heme into equimolar quantities of carbon monoxide(CO),biliverdin and Fe^(2+).HO-1 is a recognized protective agent,which has anti-inflammatory and antioxidant effects and participates in the regulation of cell proliferation,apoptosis,autophagy and other important life processes,and plays a protective role in various tissue injuries.Multiple studies have shown that HO-1 plays an important role in protecting gastrointestinal tissues and cells and has adaptive expression in a variety of gastrointestinal diseases including non-steroidal anti-inflammatory drugs(NSAIDs)related gastrointestinal injury,inflammatory bowel disease disease(IBD),intestinal ischemia-reperfusion injury,gastrointestinal tumor,gastroparesis.We reviewed the role and mechanism of HO-1 in the prevention and treatment of gastrointestinal diseases.
作者 任萍萍 段志军 REN Pingping;DUAN Zhijun(Department of Gastroenterology,the First Affiliated Hospital of Dalian Medical University,Dalian 116011,China;Department of Gastroenterology,the Second Affiliated Hospital of Dalian Medical University,Dalian 116027,China)
出处 《大连医科大学学报》 CAS 2022年第1期69-74,共6页 Journal of Dalian Medical University
关键词 血红素氧合酶-1 炎症性肠病 消化道肿瘤 缺血/再灌注损伤 hemeoxygenase-1 inflammatory bowel diseases gastrointestinal tumor ischemia/reperfusion injury
  • 相关文献

参考文献1

二级参考文献33

  • 1[1]Kong SE,Blennerhassett LR,Heel KA,McCauley RD,Hall JC.Ischaemia-reperfusion injury to the intestine.Aust N Z J Surg1998; 68:554-561
  • 2[2]Akcakaya A,Alimoglu O,Sahin M,Abbasoglu SD.Ischemiareperfusion injury following superior mesenteric artery occlusion and strangulation obstruction.J Surg Res 2002; 108:39-43
  • 3[3]Ghosh S,Roberts N,Firmin RK,Jameson J,Spyt TJ.Risk factors for intestinal ischaemia in cardiac surgical patients.Eur J Cardiothorac Surg 2002; 21:411-416
  • 4[4]Reber PU,Peter M,Patel AG,Stauffer E,Printzen G,Mettler D,Hakki H,Kniemeyer HW.Ischaemia/reperfusion contributes to colonic injury following experimental aortic surgery.Eur J Vasc Endovasc Surg 2001; 21:35-39
  • 5[5]Kimizuka K,Nakao A,Nalesnik MA,Demetris AJ,Uchiyama T,Ruppert K,Fink MP,Stolz DB,Murase N.Exogenous IL-6 inhibits acute inflammatory responses and prevents ischemia/reperfusion injury after intestinal transplantation.Am JTransplant 2004; 4:482-494
  • 6[6]Sola A,De Oca J,Gonzalez R,Prats N,Rosello-Catafau J,Gelpi E,Jaurrieta E,Hotter G.Protective effect of ischemic preconditioning on cold preservation and reperfusion injury associated with rat intestinal transplantation.Ann Surg 2001;234:98-106
  • 7[7]Turnage RH,Kadesky KM,Bartula L,Guice KS,Oldham KT,Myers SI.Splanchnic PGI2 release and "no reflow" following intestinal reperfusion.J Surg Res 1995; 58:558-564
  • 8[8]Kaminski PM,Proctor KG.Attenuation of no-reflow phenomenon,neutrophil activation,and reperfusion injury in intestinal microcirculation by topical adenosine.Circ Res 1989;65:426-435
  • 9[9]Fujino Y,Suzuki Y,Kakinoki K,Tanioka Y,Ku Y,Kuroda Y.Protection against experimental small intestinal ischaemiareperfusion injury with oxygenated perfluorochemical.Br J Surg 2003; 90:1015-1020
  • 10[10]Deitch EA.The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure.Arch Surg 1990; 125:403-404

共引文献7

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部